Viemed Healthcare (VMD) Operating Income Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.06% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 20.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 74.18% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 90.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -18.12% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 46.60% |
| 10 | Viemed Healthcare | 373.53 Mn | 365.70 Mn | 42.83 Mn | 11.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.85% |
| Dec 31, 2025 | 29.74% |
| Sep 30, 2025 | 0.25% |
| Jun 30, 2025 | 40.90% |
| Mar 31, 2025 | 74.27% |
| Dec 31, 2024 | 21.99% |
| Sep 30, 2024 | 33.81% |
| Jun 30, 2024 | 24.65% |
| Mar 31, 2024 | 13.96% |
| Dec 31, 2023 | 49.66% |
| Sep 30, 2023 | 186.32% |
| Jun 30, 2023 | 189.81% |
| Mar 31, 2023 | -13.97% |
| Dec 31, 2022 | -24.24% |
| Sep 30, 2022 | -49.67% |
| Jun 30, 2022 | -62.42% |
| Mar 31, 2022 | 68.77% |
| Dec 31, 2021 | -11.43% |
| Sep 30, 2021 | -27.75% |
| Jun 30, 2021 | -79.28% |
| Mar 31, 2021 | -71.14% |
| Dec 31, 2020 | 95.73% |
| Sep 30, 2020 | 84.81% |
| Jun 30, 2020 | 672.78% |
| Mar 31, 2020 | 99.27% |
| Dec 31, 2019 | -7.68% |
| Sep 30, 2019 | -12.94% |
| Jun 30, 2019 | -27.27% |
| Mar 31, 2019 | -1.11% |